Ovarian Cancer

Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Ovarian Cancer Information Center has current, evidence-based information for you. Get the facts about ovarian cancer prevention, early detection, treatment, and survivorship, and stay up to date with ongoing ovarian cancer research that could impact your treatment decisions through our daily cancer news.

CancerConnect Ovarian Cancer Community & Discussions

You are not alone—The CancerConnect Ovarian Cancer Community is the leading Social Media Application for Ovarian Cancer patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.

OVARIAN CANCER NEWS TIPS & FEATURES

Gradalis Announces a Novel Combination Study of Vigil® EATC in Women with Advanced Ovarian Cancer

January 11th, 2017

Gradalis Announces a Novel Combination Study of Vigil® EATC in Women with Advanced Ovarian Cancer

Gradalis, Inc. a clinical stage cellular immunotherapy company, developing Vigil® Engineered Autologous Tumor Cell (EATC) therapy, announced that it has entered into a collaboration agreement […]


FDA Approves Avastin® (Bevacizumab) Plus Chemotherapy for Treatment of Advanced Ovarian Cancer

December 26th, 2016

FDA Approves Avastin® (Bevacizumab) Plus Chemotherapy for Treatment of Advanced Ovarian Cancer

Genentech announced that the U.S. Food and Drug Administration (FDA) has approved Avastin® (bevacizumab) either in combination with carboplatin and paclitaxel or in combination with carboplatin […]


Rubraca™ Is Granted Accelerated Approval for Advanced Ovarian Cancer

December 20th, 2016

Rubraca™ Is Granted Accelerated Approval for Advanced Ovarian Cancer

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Rubraca™ (rucaparib) for the treatment of women with advanced ovarian cancer who have […]


It’s in the Genes: Genetic Testing Tutorial

November 9th, 2016

It’s in the Genes: Genetic Testing Tutorial

Advances in genetic testing are offering women more information than ever before about their genetic makeup and are providing opportunities for empowered decision making related […]


Lynparza™ Clinical Trial Demonstrates Survival Benefit in Relapsed Ovarian Cancer

November 9th, 2016

Lynparza™ Clinical Trial Demonstrates Survival Benefit in Relapsed Ovarian Cancer

AstraZeneca has announced positive results from the Phase III SOLO-2 trial designed to determine the efficacy of LynparzaTM (olaparib) oral therapy for the maintenance treatment […]


Update on PARP Inhibitors for Ovarian Cancer with BRCA Mutations

October 31st, 2016

Update on PARP Inhibitors for Ovarian Cancer with BRCA Mutations

Each year in the United States, roughly 22,000 women are diagnosed with ovarian cancer and more than 15,000 die of the disease. Treatment for ovarian […]


Tesaro Provides Real Benefit to Ovarian Cancer Patients

October 20th, 2016

Tesaro Provides Real Benefit to Ovarian Cancer Patients

Patients with platinum-sensitive recurrent ovarian cancer showed significantly improved cancer-free survival with Tesaro (niraparib) in the first clinical trial directly comparing a poly(ADP)-ribose polymerase (PARP) […]


FDA Warns Against Ovarian Cancer Screening Tests

October 6th, 2016

FDA Warns Against Ovarian Cancer Screening Tests

According to the US Food and Drug Administration (FDA) doctors and their patients should not use certain ovarian cancer screening tests because of inaccurate results. […]


National Ovarian Cancer Coalition Launches CancerConnect Social Media Platform for Women with Ovarian Cancer

September 26th, 2016

National Ovarian Cancer Coalition Launches CancerConnect Social Media Platform for Women with Ovarian Cancer

Austin TX/Sun Valley ID–The National Ovarian Cancer Coalition (NOCC) now offers a specialized social network for women with ovarian cancer. The NOCC CancerConnect Community offers […]


Pass it On: It’s National Ovarian Cancer Awareness Month

September 15th, 2016

Pass it On: It’s National Ovarian Cancer Awareness Month

In 2016, the American Cancer Association estimates that 22,280 women will be diagnosed with ovarian cancer, and 14,240 women will die from the disease. The […]


More News →